Compare SCLX & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | LFT |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | 34 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 58.2M |
| IPO Year | N/A | N/A |
| Metric | SCLX | LFT |
|---|---|---|
| Price | $6.11 | $1.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 97.8K | ★ 142.2K |
| Earning Date | 04-10-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 18.49% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $122.52 | $668.15 |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | ★ N/A | $13.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $1.04 |
| 52 Week High | $34.27 | $2.65 |
| Indicator | SCLX | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 36.35 |
| Support Level | $6.20 | $1.04 |
| Resistance Level | $7.77 | $1.40 |
| Average True Range (ATR) | 0.77 | 0.05 |
| MACD | -0.20 | -0.00 |
| Stochastic Oscillator | 11.79 | 21.88 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.